| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |